EMEA Refines Post-Market Renewal Requirements To One Five-Year Review
Executive Summary
The European Medicines Agency will require all products to have one review five years after marketing authorization, effective Nov. 20, 2005
You may also be interested in...
EU Drug Applications Will Need Pharmacovigilance Plans In 2005
Pharmaceutical drug marketing applications to the European Medicines Agency will require a pharmacovigilance plan beginning in November 2005
EU Drug Applications Will Need Pharmacovigilance Plans In 2005
Pharmaceutical drug marketing applications to the European Medicines Agency will require a pharmacovigilance plan beginning in November 2005
Drug Safety Changes Should Await IoM, HHS Secretary Tells Congress
HHS Secretary Michael Leavitt is urging Congress to be patient in considering potential changes to FDA's regulation of drug safety